Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NT5E | P21589 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amitrole SCHEMBL11745846 | 0.91 | KDM4E (0.32) | KDM4E | |
| Cadaverine Tartrate SCHEMBL9751938 | 0.84 | KDM4E (0.31) | TSHRKDM4EHSD17B10 | |
| Amitrole SCHEMBL788110 | 0.82 | HSP90AA1 (0.33) | — | |
| Amitrole SCHEMBL44637 | 0.82 | — | — | |
| Amitrole SCHEMBL10550888 | 0.79 | — | — | |
| Amitrole SCHEMBL10399233 | 0.79 | — | — | |
| Amitrole SCHEMBL31379743 | 0.79 | — | — | |
| Amitrole SCHEMBL2892139 | 0.78 | — | — | |
| Amitrole SCHEMBL1172473 | 0.75 | RXFP1 (0.45) | CA5ACA5B | |
| Amitrole SCHEMBL5613985 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10357030-B2 | Methods for generating high aspect-ratio polymeric particles comprising an active ingredient | SYNGENTA PARTICIPATIONS AG (CH) | 2019-07-23 | — | — | US | disclosed |
| US-20180303085-A1 | METHODS FOR GENERATING HIGH ASPECT-RATIO POLYMERIC PARTICLES COMPRISING AN ACTIVE INGREDIENT | SYNGENTA PARTICIPATIONS AG (CH) | 2018-10-25 | — | — | US | disclosed |
| US-10004223-B2 | Methods for generating high aspect-ratio polymeric particles comprising an active ingredient | SYNGENTA CROP PROTECTION LLC (US) | 2018-06-26 | — | — | US | disclosed |
| US-20120329648-A1 | METHODS FOR GENERATING HIGH ASPECT-RATIO POLYMERIC PARTICLES COMPRISING AN ACTIVE INGREDIENT | SYNGENTA CROP PROTECTION LLC (US) | 2012-12-27 | — | — | US | disclosed |
| EP-2498598-A1 | METHODS FOR GENERATING HIGH ASPECT RATIO POLYMERIC PARTICLES COMPRISING AN ACTIVE INGREDIENT | Syngenta Participations AG (CH) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011060210-A1 | METHODS FOR GENERATING HIGH ASPECT RATIO POLYMERIC PARTICLES COMPRISING AN ACTIVE INGREDIENT | SYNGENTA PARTICIPATIONS AG (CH) | 2011-05-19 | — | — | WO | disclosed |
| WO-2008115934-A1 | METHODS FOR GENERATING NON CELLULOSE MICROFIBRES COMPRISING AN ACTIVE INGREDIENT | SYNGENTA PARTICIPATIONS AG (CH) | 2008-09-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120329648-A1 | METHODS FOR GENERATING HIGH ASPECT-RATIO POLYMERIC PARTICLES COMPRISING AN ACTIVE INGREDIENT | ALG1, AGPS, PFAS | CA1 3441/4885CA2 4383/4885TSHR 4815/4885 |
| US-20180303085-A1 | METHODS FOR GENERATING HIGH ASPECT-RATIO POLYMERIC PARTICLES COMPRISING AN ACTIVE INGREDIENT | LIPA, ALG1, PLIN3 | CA1 2851/4885CA2 3909/4885TSHR 4859/4885 |
| US-10004223-B2 | Methods for generating high aspect-ratio polymeric particles comprising an active ingredient | ALG1, AGPS, PFAS | CA1 3441/4885CA2 4383/4885TSHR 4815/4885 |
| US-10357030-B2 | Methods for generating high aspect-ratio polymeric particles comprising an active ingredient | LIPA, ALG1, PLIN3 | CA1 2851/4885CA2 3909/4885TSHR 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.